CClinicalTrials.gg
CompletedNCT06195397Updated Jan 8, 2024

Determining the Effects of an Evidence-Based Practice Education Intervention Program Applied to Nursing Students

An interventional study of Evidence-Based Education intervention in Evidence-Based Practice, sponsored by Selcuk University. Completed at 2 sites in Turkey. Open to participants aged 18 Years to 32 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-01-08.

Sponsored by Selcuk University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 1 year 10 months after the study started (first participant enrolled Feb 2022, registered Dec 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
108
Allocation
Randomized
Ages
18 Years to 32 Years
Sex
All
01

Study summary

It was planned to evaluate the effectiveness of the evidence-based practice education intervention program in 3rd year students of the Faculty of Nursing on their knowledge, attitude, behavior and future use of evidence-based practice, and their awareness and attitudes towards research and developments.

The study was parallel group (experimental-control), randomized controlled experimental design with pretest-posttest design.

It was carried out in 3rd year students of nursing department of Selçuk University Faculty of Nursing in Konya province.

Study data were collected from 108 students between February 2023 and June 2023. Nursing students in the intervention (n = 54) and control groups (n = 54) were determined by randomization method.

Read the detailed description

A total of 12 hours of Evidence-Based Education intervention was applied to students in the intervention group, spread over 7 sessions. The educational intervention was created in line with the literature. No application was given to the students in the control group. Data were collected using the Students' Knowledge, Attitudes and Behavior Towards Evidence-Based Nursing Scale and the Nursing Students' Awareness and Attitudes Towards Research and Developments in Nursing Scale.

Paired Sample T test and Wilcoxon test will be used in pre-test and post-test comparisons. Mann Whitney U, Kruskal Wallis, One Way Anova test will be applied to determine the difference between groups. Statistical significance level was accepted as p˂0.05.

02

Conditions studied

  • Evidence-Based Practice

Keywords

  • Evidence
  • Nursing Student
  • Evidence-Based Education
03

In context

Lead sponsor

Selcuk University is the lead sponsor of 248 studies on the registry; 63 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 32 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Be registered in the third year of nursing
  • Having taken a research course

Exclusion criteria

Exclusion Criteria:

  • The student suspends his/her registration or transfers to another university
  • Not volunteering to participate in the study
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
108 participants (actual)

Study arms

  • Experimental
    Experimental: Intervention Group

    A total of 12 hours of Evidence-Based Education intervention was applied to students in the intervention group, spread over 7 sessions.

    Other: Evidence-Based Education intervention

  • No intervention
    No Intervention: Control Group

    No training was given.

Interventions

  • OtherEvidence-Based Education intervention

    A total of 12 hours of Evidence-Based Education intervention was applied to students in the intervention group, spread over 7 sessions.

06

What researchers measure

Primary outcomes

  1. Knowledge, Attitude and Behavior Scale on Evidence-Based Nursing

    Knowledge, Attitude and Behavior Scale on Evidence-Based Nursing The Likert-type scale consists of four sub-dimensions: "knowledge", "attitude", "future use" and "application" and 26 items. Although the scale does not have a total score, each sub-dimension is evaluated separately. A high score indicates that the student has more knowledge.

    Time frame: Change from baseline and post test (after 14 weeks).

  2. Nursing Students' Awareness and Attitude Scale to Research and Developments

    The scale is a five-point Likert type (strongly disagree = 1, strongly agree = 5) and consists of 29 items, 17 of which are positive and 12 of which are negative, and has a single sub-dimensional. The scores that can be obtained from the scale vary between 29-145. A high average score indicates that awareness and positive attitude towards research is high.

    Time frame: Change from baseline and post test (after 14 weeks).

07

Study locations

2 sites
  • Selcuk University
    Konya, Selcuklu 42060, Turkey
  • Selcuk University
    Konya, Turkey
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 8, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06195397
Lead sponsor
Selcuk University
Responsible party
Fatma Taş Arslan (Professor, Selcuk University) — Principal investigator
First posted
Jan 8, 2024
Start date
Feb 12, 2022
Primary completion
May 31, 2022
Completion
Jun 14, 2023
Last update
Jan 8, 2024

Study contacts

Fatma Taş Arslan, PhD
principal investigator · Selcuk University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion